Scientific Information

Organising Institutions

World Association of Probiotics, Prebiotics, Postbiotics in Pediatric

Congress Committees

 
 

Scientific Programme

08:00-10:00

Participants Registration and welcome coffee

10:00-10:30

OPENING CEREMONY

Chaired by: Flavia Indrio, Alexis Mosca, Ener Çağrı Dinleyici, Nicholas Embleton, Pedro Gutierrez, Metehan Özen, Yvan Vandenplas, Ruggiero Francavilla
Welcome and introduction by the funding members of the World Association of Probiotics, Prebiotics in Pediatrics (WAPPP)

10:30-13:00

SESSION 1 - MICROBIOTA IN PERINATOLOGY

Chair: Metehan Ozen, Turkey

10:30-10:50

Intestinal colonization during the first 1000 days

Flavia Indrio, Italy

10:50-11:10

Microbiota in pregnancy to be or not to be

David Macintyre, United Kingdom - Maria Jenmalm, Sweden

11:10-11:30

FMT from mother to newborn born by C-section

Otto Helve, Finland

11:30-11:45

QUESTIONS AND ANSWERS

11:45-12:05

ORAL COMMUNICATIONS (2 presentations of 10 minutes each)

-

THE EFFECTS OF DUAL STRAIN PROBIOTIC ON THE GROWTH AND FEEDING INTOLE ANCE IN PREMATURE NEONATES OF KABUL CITY: A RANDOMIZED CLINICAL TRIAL.T

Mansoor Aslamzai, Kabul University of Medical Science, Kabul, Afghanistan

-

BOTH SINGLE DOSE AND 3-WEEK CONSUMPTION OF GOS: FOS PREBIOTIC MIX FROM A WHEAT-BASED CEREAL CONTAINING FERROUS FUMARATE INCREASES IRON ABSORPTION IN KENYAN INFANTS

Raphaelle Bourdet-sicard, Danone Nutricia Research, Palaiseau, France

12:05-12:30

QUESTIONS AND ANSWERS WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

12:30-13:30

The role of L. reuteri and vitamin D in prevention and treatment of infections. New clinical evidence in children with tonsillitis and pharyngitis

Moderator: Ruggiero Francavilla (Italy)
Speakers: Diego Peroni (Italy), Pedro Gutiérrez-Castrellón (Mexico)

14:00-16:00

SESSION 2 - THE MAGIC MICROBIOTA OF BREAST MILK

Chair: Yvan Vandenplas, Belgium

14:00-14:20

Microbiota of the breast milk

Carmen Collado, Spain

14:20-14:40

Human milk microbiome in preterm newborn

Arianna Aceti, Italy

14:40-15:00

The influence of milk diet on immune development in pre-term infants

Janet Berrington, United Kingdom

15:00-15:15

QUESTIONS AND ANSWERS

15:15-15:45

ORAL COMMUNICATIONS (3 presentations of 10 minutes each)

-

CAN WE PREVENT ATOPIC DERMATITIS - COMBINATION OF LACTOBACILLUS RHAMNOSUS LGG, VITAMIN D3 AND ZN?

Ivana Filipovic, Hospital For Gynecology And Obstetric - Neonatology Department, University Hospital Dr Dragisa Misovic, Begrade, Serbia, Belgrade, Serbia

-

IN VITRO EVALUATION OF COMMERCIAL PROBIOTIC PRODUCTS CONTAINING STREPTOCOC-CUS SALIVARIUS K12 AND POSITIONED FOR THE PREVENTION OF RESPIRATORY INFECTIONS IN CHILDREN

Medana Zamfir, Institute Of Biology Bucharest, Bucharest, Romania

-

NECROTISING ENTEROCOLITIS, LATE ONSET SEPSIS AND MORTALITY AFTER ROUTINE PROBIO-TIC INTRODUCTION IN UK

Claire Granger, Newcastle Neonatal Services, Royal Victoria Infirmary, Newcastle, United Kingdom

15:45-16:00

QUESTIONS AND ANSWERS WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

16:00-16:30

COFFEE BREAK

16:30-18:30

SESSION 3 - PROBIOTIC IN NEONATOLOGY

Chair: Ruggiero Francavilla, Italy

16:30-16:50

Probiotic and NEC: what’s new?

Chris Van den Akker, the Netherlands

16:50-17:10

Lung microbiota newborn and BPD

Gianni Vento, Italy

17:10-17:30

Developmental Multi-omics: Trying to Paint the Complete Picture

Josef Neu, United States

17:30-17:45

QUESTIONS AND ANSWERS

17:45-18:15

ORAL COMMUNICATIONS (3 presentations of 10 minutes each)

-

IMMUNOGLOBULIN A IN COLOSTRUM IS LOWER IN INFANTS WHO GO ON TO DEVELOP NE-CROTISING ENTEROCOLITIS (NEC)

Claire Granger, Royal Victoria Infirmary, Newcastle, United Kingdom

-

PROBIOTICS USE IN FRENCH AND EUROPEAN NEONATAL UNIT CARE

Amelie Blanchetiere, University hospital of Caen, Caen, France

-

SHAPING THE INFANT GUT MICROBIOME – THE ROLE OF STRAIN TRANSMISSION

Pernille Neve Myers 1,2, Gustav Lindved 1, Susanne Brix Pedersen 2, Henrik Bjørn Nielsen 1 1. Clinical Microbiomics, Fruebjergvej 3, 2100 København 2. Technical University of Denmark, Department of Biotechnology and Biomedicine, Søltofts Plads, 2800 Kongens-Lyngby

18:15-18:30

QUESTIONS AND ANSWERS WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

18:30-19:30

The first 1000 days - environmental risk factors, microbiota dysbiosis and the role of synbiotics

Chair: Prof. Jan Knol, the Netherlands

-

The first 1000 days - importance of a balanced gut microbiota

Prof. Seppo Salminen, Finland

-

Gut microbiota dysbiosis and the role of nutrition

Dr. Guus Roeselers, the Netherlands

08:30-10:30

SESSION 4 - MICROBIOTA IN PEDIATRIC GASTRO-ENTEROLOGY

Chairs: Ener Çağrı Dinleyici, Turkey and Pedro Gutie-rrez, Mexico

08:30-08:50

Probiotics in Pediatric GI disorders

Hania Szajewska, Poland

08:50-09:10

Acute infection diarrhea

Ener Cagri Dinleyici, Turkey

09:10-09:30

Celiac disease and microbiota

Ruggiero Francavilla, Italy

09:30-09:45

QUESTIONS AND ANSWERS

09:45-10:05

ORAL COMMUNICATIONS (2 presentations of 10 minutes each)

-

ANTAGONISTIC ACTIVITY OF STREPTOCOCCUS SALIVARIUS K12 AGAINST PATHOGENIC AND OPPORTUNISTIC MICROORGANISMS

Vladislav Andreev, Smolensk State Medical University, Smolensk, Russian Federation

-

TERM INFANT FORMULA WITH A UNIQUE BLEND OF FIVE HUMAN MILK OLIGOSACCHARIDES SUPPORTS GUT DEVELOPMENT CLOSER TO THAT OF BREASTFED INFANTS

Colin Cercamondi, Nestlé Product Technology Center–Nutrition, Société des Produits Nestlé S.A., Vevey, Switzerland

10:05-10:30

QUESTIONS AND ANSWERS WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

10:30-11:00

COFFEE BREAK

11:00-13:30

SESSION 5 - PROBIOTIC PREBIOTIC POSTBIOTIC SYNBIOTIC: ANY DIFFERENCE?

Chair: Alex Mosca

11:00-11:20

Postbiotic: a new era?

Gabriel Vinderola, Argentina

11:20-11:40

Probiotic Strain specificity and strain interaction: new or old concept?

Bruno Pot, Belgium

11:40-12:00

Prebiotics and HMO

Pedro Gutierrez, Mexico

12:00-12:20

Synbiotic

Mary Ellen Sanders, USA

12:20-12:35

QUESTIONS AND ANSWERS

12:35-12:55

ORAL COMMUNICATIONS (2 presentations of 10 minutes each)

-

SPECIFIC EFFECTS OF A SYNBIOTIC INFANT FORMULA ON GUT MICROBIOTA PROFILES AND IN-FANT HEALTH

Thomas Clavel, Functional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany

-

TOLERABILITY AND COMPLIANCE OF LIVE VAGINAL BIOTHERAPEUTICS IN A COHORT OF PRE-GNANT WOMEN AT HIGH RISK OF PRETERM BIRTH

Erna Bayar, Imperial College London, London, United Kingdom, 2Osel, Mountain View, USA

12:55-13:30

QUESTIONS AND ANSWERS WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

13:30-14:30

Milk bioactives and probiotics in children: current trends and future directions

13:30-13:35

Introduction

Randy Urtula, Philippines

13:35-13:50

Prebiotics and Probiotics in Children: Current Trends and Future Directions

Randy Urtula, Philippines

13:50-14:15

Functional insights in HMOs, key early life bioactives

Hanne Tytgat, Switzerland

14:15-14:30

Live Q&A

14:30-16:40

SESSION 6 - MICROBIOTA THE NEW FRONTIERS Chaired: Member of WAPPP

Chair: Yvan Vandenplas, Belgium

14:30-14:50

Gut brain microbiota axis

Siobhain O’Mahony, Ireland

14:50-15:10

Personalized nutrition in GI disease and microbiota

Kostas Gerasimidis, United Kingdom

15:10-15:30

Fecal Microbiota Transplantation

Alexis Mosca, France

15:30-15:50

Role of gut microbiota in the development of diabetes

Elvira Verduci, Italy

15:50-16:05

QUESTIONS AND ANSWERS

16:05-16:25

ORAL COMMUNICATIONS (2 presentations of 10 minutes each)

-

WHICH PROBIOTIC IS MOST SUITABLE FOR THE PREVENTION OF NEONATAL JAUNDICE?

Д -р Tatyana Itova, University Hospital Medica Ruse, Ruse, Bulgaria

-

ANTIMICROBIAL PROPHYLAXIS IN C-SECTION BEFORE VS AFTER CORD CLAMPING: RISK OF SURGICAL SITE INFECTIONS

Enkeleda Prifti, UHOG ‘Koço Gliozheni, Tirana, Albania

16:25-16:40

QUESTIONS AND ANSWERS WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

09:00-10:30

SESSION 7 - MICROBIOTA AND ALLERGY

Chair: Ener Çağrı Dinleyici, Turkey

09:00-09:20

Gastro-intestinal microbiome and allergy

Seppo Salminen, Finland

09:20-09:40

Human milk oligosaccharides: do they contribute to the treatment of cow milk allergy?

Anna Nowak-Wegrzyn, United States

09:40-10:00

Do antibiotics and proton pump inhibitors increase the risk to develop allergy?

Yvan Vandenplas, Belgium

10:00-10:30

QUESTIONS AND ANSWERS, WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

10:30-11:00

COFFEE BREAK

11:00-13:30

SESSION 8 - GOOD AND BAD MICROBES: ROLE OF MICROBIOTA COMPOSITION / DIVERSITY

Chair: Flavia Indrio, Italy
Round table SARS-COVID 2 and microbiota

11:00-11:20

COVID in children why so different?

Susanna Esposito, Italy

11:20-11:20

Covid and Microbiota any link?

Vassilios Fanos, Italy

11:40-12:00

Covid and breast milk any link?

Hans Van Goudoever, the Netherlands

12:00-12:30

URTI prevention and Microbiota

Metehan Özen, Turkey

12:30-13:00

QUESTIONS AND ANSWERS, WRAP UP OF THE SESSION AND TAKE HOME MESSAGES

13:00-13:30

CLOSING REMARKS

Thursday – October 7, 2021

12:30-13:30

The role of L. reuteri and vitamin D in prevention and treatment of infections. New clinical evidence in children with tonsillitis and pharyngitis

Moderator: Ruggiero Francavilla (Italy)
Speakers: Diego Peroni (Italy), Pedro Gutiérrez-Castrellón (Mexico)


session supported by BIOGAIA

18:30-19:30

The first 1000 days - environmental risk factors, microbiota dysbiosis and the role of synbiotics

Chair: Prof. Jan Knol, the Netherlands

-

The first 1000 days - importance of a balanced gut microbiota

Prof. Seppo Salminen, Finland

-

Gut microbiota dysbiosis and the role of nutrition

Dr. Guus Roeselers, the Netherlands

session supported by DANONE


Friday - October 8, 2021

13:30-14:30

Milk bioactives and probiotics in children: current trends and future directions

13:30-13:35

introduction

Randy Urtula, Philippines

13:35-13:50

Prebiotics and Probiotics in Children: Current Trends and Future Directions

Randy Urtula, Philippines

13:50-14:15

Functional insights in HMOs, key early life bioactives

Hanne Tytgat, Switzerland

14:15-14:30

Live Q&A



session supported by Nestlé

Invited Speakers

 
 
 
 
 
 

Accreditations

More information will be available soon